The Department of Veterans Affairs (VA) is partnering with the Department of Defense (DoD) and the National Cancer Institute (NCI) to tailor cancer care for patients based on the genes and proteins associated with their tumors. The new Applied Proteogenomics Organizational Learning and Outcomes consortium (APOLLO) will create the nation's first system in which cancer patients' tumors are routinely screened for gene and protein information with the goal of finding targeted therapies for each individual patient. APOLLO will initially focus on lung cancer in patients at VA and DoD medical centers with plans to eventually include other forms of cancer. VA medical centers will also expand their participation in NCI's network of clinical trial sites.
For more on veteran benefits, visit the Military.com Benefits Center.
